Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria

Nigerian Journal of Clinical Practice

Volumn 16, Issue 2, 2013, Pages 249-252

  Ugwu, E O ^a   Obi, S N ^a   Ezechukwu, P C ^a   Okafor, I I ^a   Ugwu, A O ^b  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b ENUGU STATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Nigeria)

Author keywords

Acceptability; Health workers; HPV vaccine; Nigeria

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MIDDLE AGED; NIGERIA; UTERINE CERVIX TUMOR; UTILIZATION REVIEW; VIROLOGY;

ADULT; AGED; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; MIDDLE AGED; NIGERIA; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84879917231     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.110141     Document Type: Article

References (20)

1. Sankaranarayanan R. Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95(Suppl 1):S205-10.
2. Okonufua F. HPV vaccine and prevention of cervical cancer in Africa. Afr J Reprod Health 2007;11:7-12.
3. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV-medicated cervical carcinogenesis: Concepts and Clinical Implication. J Pathol 2006;208:152-64.
4. Castilaw D, Wittet S. Preventing cervical cancer: Unprecedented opportunities for improving women's health 2007; Outlook July 23. Available from http://www.rho.org/files/PATH Outlook 23.1. [Last assessed on 2012 Jan 8].
5. Frazer H. Human papilloma virus vaccine. Int J Gynecol Obstet 2006;94:381-8.
6. Stanley M. Human Papilloma Virus Vaccines versus cervical cancer screening. Clin Oncol (R Coll Radiol) 2008;20:388-94.
7. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Rotell- Martin CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papilloma virus types 16 and 18: Follow-up from a randomised control trial. Lancet 2006;367:1247-55.
8. Riedesel JM, Rosenthal SL, Zimet GD, Bemstein DI, Huang B, et al. Attitudes about human Papilloma virus vaccine among family physicians. J Paediatr Adolescent Gynaecol 2005;18:391-8.
9. Enugu State of Nigeria, Poverty Reduction Strategy/State Economic Empowerment and Development Strategy (PRS/SEEDS) 2004-2009, Ministry of Human Developments and Poverty and Reduction Enugu State. 2004; 13-38. Available from http://www.ebeano.org/poverty-reduction-strategy.doc [Last assessed on 2012 Sept 16].
10. Federal Republic of Nigeria. 2006 Population Census. Available from http://www.nigerianstat.gov.ng/nbsapps/Connections/Pop2006. [Last assessed on 2012 Feb 18].
11. Di Aangi YT, Panozzo CA, Ramogola-Masire D, Steenhoff AP, Brewer NT. A cross-sectional study of HPV vaccine acceptability in Gaborone, Botswana. PLoS One 2011;6:e25481. PubMed PMID: 22039412.
12. IIiyasu Z, Abubakar IS, Aliyu MH, Galadanci HS. Cervical cancer risk perception and predictors of human papilloma virus vaccine acceptance among female university students in northern Nigeria. J Obstet Gynaecol 2010;30:857-62.
13. Coleman MA, Levison J, Sangi-Haghapeykar H. Human pappiloma virus vaccine acceptability in Ghana, West Africa. Vaccine 2011;29:3945-50.
14. Becker-Dreps S, Otieno WA, Brewer NT, Agot K, Smith JS. Human papilloma virus vaccine acceptability among Kenyan women. Vaccine 2010;28:4864-7.
15. Remes P, Selestine V, Chanqalucha J, Ross DA, Wight D, de Sanjose S, et al. A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine 2012;30:5363-7.
16. Bingham A, Drake JK, La Montagne DS. Socio-cultural issues in the introduction of human papilloma virus vaccine in low-resource settings. Arch Pediatr Adolesc Med 2009;163:455-61.
17. Dim CC, Ekwe E, Madubuko T, Dim NR, Ezegwui HU. Improved awareness of Pap smear may not affect its use in Nigeria: A case study of female medical practitioners in Enugu, southeastern Nigeria. Trans R Soc Trop Med Hyg 2009;103:852-4.
18. Wellensiek N, Moodley M, Moodley J, Nkwanyana N. Knowledge of cervical cancer screening and use of cervical screening facilities among women from various socioeconomic backgrounds in Durban, Kwazulu Natal, South Africa. Int J Gynecol Cancer 2002;12:376-82.
19. Larsen LP, Olesen F. Women's knowledge and attitude towards organized cervical smear screening. Acta Obstet Gynecol Scand 1998;77:988-96.
20. Millstein SG. Utility of the theories of reasoned action and planned behavior for predicting Physician behavior: A prospective analysis. Health Psychol 1996;15:398-402.